Objective: The aim of this study was to review the indications, procedure, and complications associated with primary gastrectomy in women undergoing primary debulking of ovarian cancer. Materials and Methods: Charts were reviewed to determine which patients were undergoing partial gastrectomy during primary debulking of ovarian, peritoneal, or fallopian-tube cancer. Charts were also reviewed for perioperative morbidity and mortality, including gastric leak rates. Results: Eleven (11) patients underwent the above procedure during primary debulking of ovarian cancer. The patients' mean age was 61 and they had mean body–mass index of 34 kg/m2. The average postoperative hospital stay was 11 days with an average estimated blood loss of 600 mL. There was no perioperative mortality. One staple line leak was encountered and was treated without reoperation. Conclusions: Radical surgery, including partial gastrectomy, can be performed in certain patients who have primary ovarian cancer to obtain adequate cytoreduction. Acceptable morbidity and mortality can be obtained. (J GYNECOL SURG 26:243)
Get full access to this article
View all access options for this article.
References
1.
JemalA, SiegelR, WardE, HaoY, XuJ, MurrayT, ThunMJ. Cancer Statistics, 2008. CA Cancer J Clin, 2008; 58:71.
2.
ChiDS, EisenhauerELet al.What is the goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)?Gynecol Oncol, 2006; 103:559.
3.
BristowRE, Smith SehdevAE, KaufmanHS, MontzFJ. Ablation of metastatic ovarian carcinoma with the argon beam coagulator: Pathologic analysis of tumor destruction. Gynecol Oncol, 2001; 83:49.
4.
BristowRE, MontzFJ. Complete surgical cytoreduction of advanced ovarian carcinoma using the argon beam coagulator. Gynecol Oncol, 2001; 83:39.
5.
ChiDS, DiazJP, JamaginWR. Distal partial gastrectomy and gastrojejunal anastamosis for recurrent ovarian cancer. Gynecol Oncol, 2007; 104:S33.
6.
HaneyJC, D'AmicoTA. Transhiatal esophagogastrectomy for an isolated ovarian cancer metastasis to the esophagus. J Thoracic Cardiovasc Surg, 2004; 127:1835.
7.
GeasFL, TewariDS, RutgersJK, TewariKS, BermanML. Surgical cytoreduction and hormone therapy of an advanced endometrial stromal sarcoma of the ovary. Obstet Gynecol, 2004; 103,5pt2:1051.
8.
Angiology: The arteries of the trunk. WilliamsPL, WarwickR, DysonM, BannisterLH. Gray's Anatomy, 37th. Churchill Livingstone: New York, 1989; 764.
9.
Splanchnology: Abdominal viscera. WilliamsPL, WarwickR, DysonM, BannisterLH. Gray's Anatomy, 37th. Churchill Livingstone: New York, 1989; 1347.
10.
PedrazzaniC, MarrelliD, RamponeBet al.Postoperative complications and functional results after subtotal gastrectomy with Billroth II reconstruction for primary gastric cancer. Dig Dis Sci, 2006; 52:1757.
11.
La GrecaG, RandazzoV, BarbagalloFet al.Laparoscopic resection of a large GIST of the stomach: Is it preferable in elderly patients? A case report. Chirurg Ital, 2008; 60:135.
HoskinsWJ, BundyBN, ThigpenJT, OmuraGA. The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: A Gynecologic Oncology Group study. Gynecol Oncol, 1992; 47:159.
McGuireWP, HoskinsWJ, BradyMFet al.Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med, 1996; 334:1.
19.
BhoolaS, HoskinsWJ. Diagnosis and management of epithelial ovarian cancer. Obstet Gynecol, 2006; 107:1399.
20.
HoffmanMS, TebesSJ, SayerRA, LockhartJ. Extended cytoreduction of intraabdominal metastatic ovarian cancer in the left upper quadrant utilizing en bloc resection. Am J Obstet Gynecol, 2007; 197:209.
21.
SpirtosNM, GrossGM, FreddoJL, BallonSC. Cytoreductive surgery in advanced epithelial cancer of the ovary: The impact of aortic and pelvic lymphadenectomy. Gynecol Oncol, 1996; 51:23.
